RELAY THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Description as filed by funds: To elect two class I directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Linda A. Hill, Ph.D.

RELAY THERAPEUTICS INC.’s own tally for this item (“Elect Director: Linda A. Hill, Ph.D.”): 91,335,004 for, 20,111,439 withheld, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected each of the following individuals to serve as class I directors for a three-year term ending at the Company's 2027 annual meeting of stockholders and until his or her respective successor is duly elected and qualified, or until his or her earlier death, resignatio…”
Support: 82% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 66 asset managers below reported 31,051,461 for, 7,694,619 withheld.

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

Description as filed by funds: To elect two class I directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Sanjiv K. Patel, M.D.

RELAY THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sanjiv K. Patel, M.D.”): 109,894,794 for, 1,587,504 withheld, per its Form 8-K filed June 3, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The Company's stockholders elected each of the following individuals to serve as class I directors for a three-year term ending at the Company's 2027 annual meeting of stockholders and until his or her respective successor is duly elected and qualified, or until his or her earlier death, resignatio…”
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 66 asset managers below reported 37,661,272 for, 1,084,808 withheld.

Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.

Description as filed by funds: To consider and act upon an advisory vote on the compensation of our named executive officers;

RELAY THERAPEUTICS INC.’s own tally for this item (“2. Non-binding advisory vote on executive compensation”): 66,749,846 for, 44,678,968 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers, with the votes cast as follows:”
Support: 60% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 66 managers: 15,391,427 for, 23,321,283 against, 33,370 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 150 managers: 41,990,489 for, 36,030,249 against. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and

RELAY THERAPEUTICS INC.’s own tally for this item (“3. Ratification of appointment of independent registered public accounting firm”): 119,407,293 for, 19,856 against — passed, per its Form 8-K filed June 3, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 38,738,613 for, 14,951 abstained.

Showing the 25 largest of 67 asset managers. See all 67 in the interactive database.